Outsourcing Innovation eBook February 2024
Read the article: A Closer Look at Affinity Ligands
Read the eBook: Pharmaceutical Technology/Pharmaceutical Technology Europe Outsourcing Innovation eBook February 2024
CONTINUE TO SITE
OR WAIT null SECS
Advertisement
- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2025 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
A Closer Look at Affinity Ligands
Published on:
Daria G. Husni
Pharmaceutical Technology, Bio/Pharma Outsourcing Innovation, February 2024 eBook, Volume 2024 eBook, Issue 2
Pages: 16-21
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
Affinity ligands play an exciting role in the ever-growing sphere of downstream processing. In speaking with Pharmaceutical Technology®, Phillip Elliott, PhD, associate director of Process Development, BioCina; Jan Bekker, PhD, director, Business Development, Commercial and Technical Operations, BioCina; and Parviz Shamlou, PhD, senior vice-president of Science & Technology, Abzena illuminate the newest innovations with affinity ligands and provide a deeper understanding of the role affinity ligands play in the future of downstream processing.
Read this article in Pharmaceutical Technology’s Bio/Pharma Outsourcing Innovation eBook.
Advertisement
About the author
Daria Husni is assistant editor to Pharmaceutical Technology® and Pharmaceutical Technology Europe®.
Article details
Pharmaceutical Technology/Pharmaceutical Technology Europe Outsourcing Innovation eBook
Issue 2
February 2024
Pages: 16-21
Citation
When referring to this article, please cite it as Husni, D. A Closer Look at Affinity Ligands. Pharmaceutical Technology, Bio/Pharma Outsourcing Innovation eBook. February 2024.
